Baseline characteristics compared between the drug-free remission group and the non-remission group.</p
Baseline characteristics of patients with MCI and patients without MCI (n = 20515).</p
<p>Baseline characteristics of the included studies: Treatment success group vs. AF recurrence group...
<p>Baseline clinical characteristics of AF group and non-AFheart disease control group.</p
Comparison of clinical characteristics between the DAS and US remission groups and the non-remission...
<p>Baseline characteristics of patients in the antiviral group and the non-antiviral group.</p
Baseline characteristics of the patients in the aleglitazar group compared with the placebo group.</...
Comparison of baseline characteristics between non-hyperuricemic and hyperuricemic subjects.</p
Comparison of baseline characteristics of participants and non-participants in the follow-up of the ...
Comparisons of baseline characteristics and clinical courses of the patient groups.</p
<p>Baseline characteristics of patients who were treated with statin and those who were not.</p
<p>Comparison of the baseline characteristics of the screening and clinical detection groups.</p
<p>Overview of differences in baseline characteristics between the group that needed additional pred...
Baseline characteristics comparing conservative versus ablation groups in asymptomatic and symptomat...
<p>Baseline characteristics for the patients in the <5 drugs and ≥5 drugs subgroups.</p
<p>Comparison of demographic, medication, treatments, and clinical characteristics between those wit...
Baseline characteristics of patients with MCI and patients without MCI (n = 20515).</p
<p>Baseline characteristics of the included studies: Treatment success group vs. AF recurrence group...
<p>Baseline clinical characteristics of AF group and non-AFheart disease control group.</p
Comparison of clinical characteristics between the DAS and US remission groups and the non-remission...
<p>Baseline characteristics of patients in the antiviral group and the non-antiviral group.</p
Baseline characteristics of the patients in the aleglitazar group compared with the placebo group.</...
Comparison of baseline characteristics between non-hyperuricemic and hyperuricemic subjects.</p
Comparison of baseline characteristics of participants and non-participants in the follow-up of the ...
Comparisons of baseline characteristics and clinical courses of the patient groups.</p
<p>Baseline characteristics of patients who were treated with statin and those who were not.</p
<p>Comparison of the baseline characteristics of the screening and clinical detection groups.</p
<p>Overview of differences in baseline characteristics between the group that needed additional pred...
Baseline characteristics comparing conservative versus ablation groups in asymptomatic and symptomat...
<p>Baseline characteristics for the patients in the <5 drugs and ≥5 drugs subgroups.</p
<p>Comparison of demographic, medication, treatments, and clinical characteristics between those wit...
Baseline characteristics of patients with MCI and patients without MCI (n = 20515).</p
<p>Baseline characteristics of the included studies: Treatment success group vs. AF recurrence group...
<p>Baseline clinical characteristics of AF group and non-AFheart disease control group.</p